Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Yohimbine (Hydrochloride)

Product Specifications

UNSPSC Description

Yohimbine hydrochloride is an alpha-2 renal adenomatase receptor inhibitor, blocking pre- and post-contact alpha-2 renal adenomatase receptors, causing the release of renal adenoma and multiple sclerosis.

Target Antigen

Adrenergic Receptor

Type

Natural Products

Related Pathways

GPCR/G Protein;Neuronal Signaling

Field of Research

Endocrinology

Assay Protocol

https://www.medchemexpress.com/Yohimbine-Hydrochloride.html

Purity

99.91

Solubility

DMSO : 8.75 mg/mL (ultrasonic;warming;heat to 60°C)|H2O : 3.33 mg/mL (ultrasonic)

Smiles

[H][C@]12C(NC3=C4C=CC=C3)=C4CCN1C[C@@]5(CC[C@H](O)[C@H](C(OC)=O)[C@]5(C2)[H])[H].[H]Cl

Molecular Weight

390.90

References & Citations

[1]Docherty JR, et al. Yohimbine antagonises α1A- and α1D-adrenoceptor mediated components in addition to the α2A-adrenoceptor component to pressor responses in the pithed rat. Eur J Pharmacol. 2012 Mar 15;679(1-3):90-4.|[2]Docherty JR. Yohimbine antagonises α1A- and α1D-adrenoceptor mediated components in addition to the α2A-adrenoceptor component to pressor responses in the pithed rat. Eur J Pharmacol. 2012 Mar 15;679(1-3):90-4.|[3]Damase-Michel C, et al. The effect of yohimbine on sympathetic responsiveness in essential hypertension. Eur J Clin Pharmacol. 1993;44(2):199-201.|[4]Musso NR, et al. Yohimbine effects on blood pressure and plasma catecholamines in human hypertension. Am J Hypertens. 1995 Jun;8(6):565-71. |[5]Sáiz J, et al. Yohimbine-induced alterations in alpha(2)-adrenoceptors in kidney regions of the spontaneously hypertensive rats: an autoradiographic analysis. Pharmacol Rep. 2008 May-Jun;60(3):391-8.Eur J Pharmacol. 2023 Nov 6:176174.|Exp Neurobiol. 2020 Oct 31;29(5):356-375.|Mol Biol Rep. 2020 May;47(5):3629-3639.|Mol Med Rep. 2020 Jul;22(1):175-184.|Neurosci Bull. 2022 Apr;38(4):386-402.|Biomed Pharmacother. 2022 Apr 26;150:113006.|Drug Des Devel Ther. 2024 Apr 9:18:1103-1114.|Eur J Neurosci. 2021 Nov 4.|J Neuroinflammation. 2022 May 27;19(1):123.|J Neurophysiol. 2023 Apr 12.|Research Square Preprint. 2023 Dec 16.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-N0127/Yohimbine-Hydrochloride-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-N0127/Yohimbine-Hydrochloride-SDS-MedChemExpress.pdf

Clinical Information

Launched

CAS Number

65-19-0

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Netrin 4 (NTN4) (NM_021229) Human Tagged Lenti ORF Clone
RC224596L4 10 µg

Netrin 4 (NTN4) (NM_021229) Human Tagged Lenti ORF Clone

Ask
View Details
EEF1D siRNA (Mouse)
MBS8240041-01 15 nmol

EEF1D siRNA (Mouse)

Ask
View Details
EEF1D siRNA (Mouse)
MBS8240041-02 30 nmol

EEF1D siRNA (Mouse)

Ask
View Details
EEF1D siRNA (Mouse)
MBS8240041-03 5x 30 nmol

EEF1D siRNA (Mouse)

Ask
View Details
hsa-miR-3200-5p miRNA Inhibitor
MBS8293889-01 10 nmol

hsa-miR-3200-5p miRNA Inhibitor

Ask
View Details
hsa-miR-3200-5p miRNA Inhibitor
MBS8293889-02 20 nmol

hsa-miR-3200-5p miRNA Inhibitor

Ask
View Details